EUR 6.0
(-0.83%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 92.42 Million EUR | 3.71% |
2022 | 89.11 Million EUR | -26.66% |
2021 | 121.5 Million EUR | -4.18% |
2020 | 126.81 Million EUR | 16.04% |
2019 | 109.28 Million EUR | 6.65% |
2018 | 102.46 Million EUR | -0.78% |
2017 | 103.26 Million EUR | -2.78% |
2016 | 106.22 Million EUR | 51.55% |
2015 | 70.08 Million EUR | 6.63% |
2014 | 65.73 Million EUR | -33.37% |
2013 | 98.64 Million EUR | 24.27% |
2012 | 79.38 Million EUR | 47.94% |
2011 | 53.65 Million EUR | -24.07% |
2010 | 70.67 Million EUR | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 Q4 | 92.42 Million EUR | 0.0% |
2023 Q2 | 91.49 Million EUR | 0.0% |
2022 FY | 89.11 Million EUR | -26.66% |
2022 Q2 | 121.74 Million EUR | 0.0% |
2022 Q4 | 89.11 Million EUR | 0.0% |
2021 Q2 | 123.87 Million EUR | 0.0% |
2021 Q4 | 121.5 Million EUR | 0.0% |
2021 FY | 121.5 Million EUR | -4.18% |
2020 Q4 | 126.81 Million EUR | 0.0% |
2020 Q2 | 128.66 Million EUR | 0.0% |
2020 FY | 126.81 Million EUR | 16.04% |
2019 Q4 | 109.28 Million EUR | 0.0% |
2019 Q2 | 101.07 Million EUR | 0.0% |
2019 FY | 109.28 Million EUR | 6.65% |
2018 FY | 102.46 Million EUR | -0.78% |
2018 Q4 | 102.46 Million EUR | 0.0% |
2018 Q2 | 102.63 Million EUR | 0.0% |
2017 Q2 | 108.35 Million EUR | 0.0% |
2017 FY | 103.26 Million EUR | -2.78% |
2017 Q4 | 103.26 Million EUR | 0.0% |
2016 Q4 | 106.22 Million EUR | 0.0% |
2016 FY | 106.22 Million EUR | 51.55% |
2016 Q2 | 100.06 Million EUR | 0.0% |
2015 Q2 | 64.52 Million EUR | 0.0% |
2015 Q4 | 70.08 Million EUR | 0.0% |
2015 FY | 70.08 Million EUR | 6.63% |
2014 FY | 65.73 Million EUR | -33.37% |
2014 Q4 | 65.73 Million EUR | 0.0% |
2014 Q2 | 124.12 Million EUR | 0.0% |
2013 Q4 | 88.12 Million EUR | 0.0% |
2013 FY | 98.64 Million EUR | 24.27% |
2012 FY | 79.38 Million EUR | 47.94% |
2011 FY | 53.65 Million EUR | -24.07% |
2010 FY | 70.67 Million EUR | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Crossject Société Anonyme | 12.72 Million EUR | -626.352% |
Safe Orthopaedics SA | 5.07 Million EUR | -1721.103% |
Spineway SA | 1.67 Million EUR | -5420.968% |
Sartorius Stedim Biotech S.A. | 3.5 Billion EUR | 97.367% |
EssilorLuxottica Société anonyme | 6.55 Billion EUR | 98.591% |
bonyf N.V. | - EUR | -Infinity% |